Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg 20246, Germany.
Neuro Oncol. 2010 Jul;12(7):645-54. doi: 10.1093/neuonc/noq002. Epub 2010 Feb 14.
Neural stem/progenitor cells (NSPCs) display inherent pathotropic properties that can be exploited for targeted delivery of therapeutic genes to invasive malignancies in the central nervous system. Optimizing transplantation efficiency will be essential for developing relevant NSPC-based brain tumor therapies. To date, the real-world issue of handling and affixing NSPCs in the context of the neurosurgical resection cavity has not been addressed. Stem cell transplantation using biocompatible devices is a promising approach to counteract poor NSPC graft survival and integration in various types of neurological disorders. Here, we report the development of a 3-dimensional substrate that is based on extracellular matrix purified from tissue-engineered skin cultures (3DECM). 3DECM enables the expansion of embedded NSPCs in vitro while retaining their uncommitted differentiation status. When implanted in intracerebral glioma models, NSPCs were able to migrate out of the 3DECM to targeted glioma growing in the contralateral hemisphere, and this was more efficient than the delivery of NSPC by intracerebral injection of cell suspensions. Direct application of a 3DECM implant into a tumor resection cavity led to a marked NSPC infiltration of recurrent glioma. The semisolid consistency of the 3DECM implants allowed simple handling during the surgical procedure of intracerebral and intracavitary application and ensured continuous contact with the surrounding brain parenchyma. Here, we demonstrate proof-of-concept of a matrix-supported transplantation of tumor-targeting NSPC. The semisolid 3DECM as a delivery system for NSPC has the potential to increase transplantation efficiency by reducing metabolic stress and providing mechanical support, especially when administered to the surgical resection cavity after brain tumor removal.
神经干/祖细胞(NSPCs)表现出固有趋向性特性,可用于将治疗基因靶向递送至中枢神经系统中的侵袭性恶性肿瘤。优化移植效率对于开发基于 NSPC 的脑肿瘤治疗方法至关重要。迄今为止,尚未解决在神经外科切除腔中处理和固定 NSPC 的实际问题。使用生物相容性设备进行干细胞移植是一种很有前途的方法,可以克服各种类型的神经障碍中 NSPC 移植物存活率和整合率低的问题。在这里,我们报告了一种基于组织工程皮肤培养物中纯化的细胞外基质的 3 维基质(3DECM)的开发。3DECM 允许在体外扩增嵌入的 NSPC,同时保留其未分化的分化状态。当植入脑内神经胶质瘤模型中时,NSPC 能够从 3DECM 中迁移出来,靶向在对侧半球中生长的神经胶质瘤,这比通过脑内注射细胞悬浮液输送 NSPC 更为有效。将 3DECM 植入物直接应用于肿瘤切除腔中,可导致复发性神经胶质瘤的 NSPC 明显浸润。3DECM 植入物的半固态一致性允许在脑内和脑室内应用的手术过程中进行简单处理,并确保与周围脑实质保持持续接触。在这里,我们证明了基质支持的肿瘤靶向 NSPC 移植的概念验证。半固态 3DECM 作为 NSPC 的递药系统,具有通过减少代谢应激和提供机械支持来提高移植效率的潜力,特别是在脑肿瘤切除后将其施用于手术切除腔时。